The number of women used ADHD medication has risen by 18.5 percent in three years. Figures from the National Institute for Sickness and Invalidity Insurance (RIZIV) show that in 2024 10,376 Women’s Methylphenidate, known as Rilatin, bought at the pharmacy, compared to 8,575 women in 2021. ‘De Morgen’ reports today.
ttn-3
